Target intelligence / Profile preview

Brown adipose tissue (BAT)

Target
BAT
Molecular classification
Other (not a single molecule; tissue composed mainly of brown adipocytes)
01

Overview

Brown adipose tissue is a highly vascularized, mitochondrial-rich tissue found in mammals, especially abundant in newborns and small mammals but also present in adults[3][4][7]. Its primary function is to produce heat via non-shivering thermogenesis, mainly through the mitochondrial protein uncoupling protein 1 (UCP1)[1][3][5][8]. BAT receives sympathetic innervation; norepinephrine stimulates β-adrenergic receptors on brown adipocytes, activating lipolysis and subsequent mitochondrial uncoupling, resulting in conversion of chemical energy into heat. Recent research has highlighted the endocrine role of BAT, with secreted factors (batokines) influencing systemic glucose and lipid metabolism. Brown adipose tissue is being actively investigated as a modulator of energy balance and a potential "therapeutic target" in obesity and metabolic diseases, though it is an organ/tissue and not a canonical molecular drug target[2][5][3]. Note: Brown adipose tissue is not a single receptor, enzyme, or protein. It is a tissue/organ, and while often called a "therapeutic target," this usage is broader than the molecular definition generally sought for pharmacological targets. If you require information about a specific *molecular target* associated with BAT (such as β3-adrenergic receptor or UCP1), please specify.

Other names
brown fatBATbrown adipocyte tissuebrown adipocytes
02

Mechanism of action

Stimulation of β3-adrenergic receptors leading to UCP1-mediated mitochondrial uncoupling and heat production

03

Biological functions

Thermogenesis (non-shivering)Energy expenditureGlucose and lipid homeostasisEndocrine signaling through secretion of batokines
04

Disease associations

ObesityType 2 diabetesMetabolic syndrome
05

Safety considerations

Off-target adrenergic stimulation (e.g. cardiac side effects with β-adrenergic agonists)Potential for excessive energy expenditure leading to weight loss or cachexia in unintended contextsUnforeseen metabolic or cardiovascular effects in long-term BAT activation
06

Interacting drugs

β3-adrenergic agonists (e.g., mirabegron, used investigationally to stimulate BAT activity)

1 more in the full profile.

07

Biomarkers

Uncoupling protein 1 (UCP1)Glucose uptake on ^18F-FDG PETLevels of secreted batokines such as neuregulin 4 (NRG4), 12,13-diHOME, 12-HEPE

Beyond the preview

Go deeper on Brown adipose tissue (BAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brown adipose tissue (BAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call